Volume 13, Issue 2 pp. 133-137
Brief Communication
Full Access

BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome

Anwar N. Mohamed MD

Corresponding Author

Anwar N. Mohamed MD

Cytogenetics Laboratory, Departments of Pathology and Internal Medicine/Harper Hospital, Wayne State University, Detroit, Michigan

Pathology Department/Cytogenetics, Wayne State University/Harper Hospital, 3990 John R, Detroit, MI 48201, U.S.A.Search for more papers by this author
F. Koppitch

F. Koppitch

Cytogenetics Laboratory, Departments of Pathology and Internal Medicine/Harper Hospital, Wayne State University, Detroit, Michigan

Search for more papers by this author
M. Varterasian

M. Varterasian

Cytogenetics Laboratory, Departments of Pathology and Internal Medicine/Harper Hospital, Wayne State University, Detroit, Michigan

Search for more papers by this author
C. Karanes

C. Karanes

Cytogenetics Laboratory, Departments of Pathology and Internal Medicine/Harper Hospital, Wayne State University, Detroit, Michigan

Search for more papers by this author
Kai-Ling Yao

Kai-Ling Yao

Cytogenetics Laboratory, Departments of Pathology and Internal Medicine/Harper Hospital, Wayne State University, Detroit, Michigan

Search for more papers by this author
F. H. Sarkar

F. H. Sarkar

Cytogenetics Laboratory, Departments of Pathology and Internal Medicine/Harper Hospital, Wayne State University, Detroit, Michigan

Search for more papers by this author
First published: June 1995
Citations: 20

Abstract

A reciprocal translocation, t(10; 22) (q22; q11), resulting in a masked Ph chromosome was identified in a patient diagnosed with chronic myeloid leukemia (CML). Both homologs of chromosome 9 were of the normal pattern. Two signals for the ABL probe, both of them hybridized to chromosome 9, were demonstrated via fluorescence in situ hybridization (FISH). Furthermore, cohybridization with two differently labeled BCR/ABL translocation DNA probes indicated a BCR/ABL fusion apparently located on 9q34. Molecular studies revealed a rearrangement of the BCR region and expression of a chimeric BCR/ABL mRNA of CML configuration. These findings indicate that the BCR/ABL fusion resulted from an unusual relocation of the BCR gene from its normal position on 22ql I to 9q34 adjacent to the ABL gene.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.